An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab
D9180C00006
Phase 1 other active
Quick answer
An Accessorised Prefilled Syringe to an Autoinjector Pharmacokinetic Bridging Study of Tozorakimab for Inflammation, Respiratory is a Phase 1 program (other) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- Inflammation, Respiratory
- Phase
- Phase 1
- Modality
- other
- Status
- active